Bioxytran and University of Minnesota Launch Sponsored Research Collaboration to Advance Novel Carbohydrate-Based Therapeutics ACN Newswire

Bioxytran and University of Minnesota Launch Sponsored Research Collaboration to Advance Novel Carbohydrate-Based Therapeutics

February 2, 2026
NEEDHAM, MA, Feb 2, 2026 - (ACN Newswire via SeaPRwire.com) - Bioxytran, Inc. (OTCQB: BIXT) (“Bioxytran” or the “Company”), a clinical-stage biotechnology company developing platform technologies spanning glycovirology, hypoxia, and degenerative diseases, announced the execution of a Sponsored Research Agreement with the University of Minnesota to support advanced biochemical research aimed at improving the understanding and development of novel polysaccharide and oligosaccharide interactions with biologically relevant targets.Under the agreement, research will be conducted at the University of Minnesota under the direction of Dr. Kevin Mayo, a recognized expert in biomolecular structure and nuclear magnetic resonance spectroscopy The collaboration is designed to further characterize carbohydrate-binding interactions that may play a role in future therapeutic and diagnostic applications.“This collaboration with the University of Minnesota represents an important step in strengthening the scientific foundation behind our carbohydrate-based technology platform,” said David Platt, CEO of Bioxytran. “By leveraging the University’s deep expertise in structural biology and advanced nuclear magnetic resonance spectroscopy, we aim to generate high-quality data that supports the continued evolution of our research and development pipeline.”Research FocusThe sponsored research program will explore how specific polysaccharides and related carbohydrate structures interact with target molecules relevant to biological systems. Using state-of-the-art nuclear magnetic resonance methodologies, the research team will analyze binding interactions, structural conformations, and affinity characteristics of select carbohydrate compounds. The work is expected to build on Bioxytran’s existing research into carbohydrate-based materials and their potential applications across biomedical and life-science domains. Findings from the study may help guide future development strategies and inform additional preclinical research initiatives.Academic–Industry CollaborationThe agreement reflects a shared commitment to advancing scientific knowledge through collaboration between academia and industry. The University of Minnesota will carry out the research in accordance with its established academic standards, ensuring scientific rigor, transparency, and adherence to institutional research policies.This type of partnership exemplifies how academic research institutions and innovative companies can work together to address complex scientific questions,” said Dr. Kevin Mayo, Principal Investigator and Professor at the University of Minnesota. “Our goal is to apply advanced analytical tools to generate insights that are both scientifically meaningful and relevant to real-world applications.”Timeline and StructureThe research term is expected to run through early 2027, with defined milestones, periodic progress reviews, and structured reporting. Bioxytran will provide funding to support research personnel, nuclear magnetic resonance facility access, and associated laboratory resources required to execute the program. In accordance with standard sponsored research practices, the University of Minnesota will retain ownership of any intellectual property generated through the research, while Bioxytran will receive broad rights to use the resulting research data for internal research and development purposes.Strategic SignificanceFor Bioxytran, the collaboration supports a broader strategy focused on strengthening its scientific validation, expanding academic partnerships, and advancing next-generation carbohydrate technologies. The company believes that well-characterized molecular interactions are a critical step toward unlocking new therapeutic pathways and accelerating innovation.The University of Minnesota continues to be recognized globally for its leadership in biomedical research and technology transfer, making it an ideal partner for companies seeking to bridge fundamental science and commercial development.About the University of MinnesotaThe University of Minnesota is one of the nation’s leading public research universities, known for its commitment to discovery, innovation, and the translation of research into real-world impact. Through industry partnerships and sponsored research programs, the University fosters collaboration that advances science and benefits society.About Bioxytran, Inc.Bioxytran is a clinical-stage pharmaceutical company developing platform technologies in glycovirology, hypoxia and degenerative diseases using carbohydrate drug design, including programs that leverage galectin inhibition and programs that aim to address hypoxic conditions and tissue oxygenation. Bioxytran’s common stock trades on the OTCQB under the symbol BIXT.Company Contact:Bioxytran, Inc.75 Second Avenue, Needham, MA 02494Phone: 617‑454‑1199Email: info@Bioxytraninc.comWeb: www.Bioxytraninc.comForward-Looking StatementsThis press release contains forward-looking statements, including statements regarding anticipated regulatory interactions, future clinical trials, trial designs, timing of data submission and publication, and potential therapeutic and commercial opportunities. Forward-looking statements are based on current expectations and are subject to risks and uncertainties that could cause actual results to differ materially. Readers are urged to review the Company’s risk factors disclosed in its reports filed with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10‑K for the year ended December 31, 2024. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Lockheed Martin and Fujitsu to accelerate dual-use technology development ACN Newswire

Lockheed Martin and Fujitsu to accelerate dual-use technology development

February 1, 2026
Bethesda, United States, and Kawasaki, Japan, Feb 2, 2026 - (JCN Newswire via SeaPRwire.com) - Lockheed Martin and Fujitsu Limited today announced a new Memorandum of Understanding (MOU) to jointly accelerate technology development in several critical areas, leveraging Lockheed Martin’s integrated systems expertise and Fujitsu’s world-leading technologies and commercial scale to advance innovation of dual-use capabilities.Through the MOU the companies plan to strengthen the technological foundation for dual-use solutions in quantum computing, edge computing enabled by advanced sensing and real-time data fusion, artificial intelligence and machine learning (AI/ML), advanced microelectronics, and multi-domain next-generation network solutions.CTO Perspectives“This collaboration accelerates technologies that are critical to meeting the future needs of our customers,” said Craig Martell, vice president and chief technology officer, Lockheed Martin. “Coupling the expertise of Lockheed Martin and Fujitsu across technology areas will be a force multiplier, advancing leadership in critical technologies like microelectronics, inference at the edge and quantum solutions. We look forward to our work together and delivering innovation with speed to our customers.“We are honored to collaborate with Lockheed Martin, a leader in defense technologies, on the development of advanced ICT technologies for future dual-use applications,” said Vivek Mahajan, corporate executive officer, corporate vice president, and chief technology officer in charge of System Platform, Fujitsu Limited. “Through this collaboration, we aim to strengthen the competitive standing of both companies.”A Continuing CollaborationThe MOU expands on a May 2025 agreement that selected Fujitsu as the supplier of Lockheed Martin’s SPY-7 Subarray Suite Power Supply Line Replaceable Unit, and established a strategic collaboration to strengthen Japan’s defense industrial base.About Lockheed MartinLockheed Martin is a global defense technology company driving innovation and advancing scientific discovery. Our all-domain mission solutions and 21st Century Security® vision accelerate the delivery of transformative technologies to ensure those we serve always stay ahead of ready. More information at www.lockheedmartin.comAbout FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers around the globe, our 113,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: AI, Computing, Networks, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$23 billion) for the fiscal year ended March 31, 2025 and remains the top digital services company in Japan by market share. Find out more: global.fujitsuPress ContactsLockheed MartinCorporate Media Relations301-214-3030E-mail: media.relations@lmco.com Fujitsu LimitedPublic and Investor Relations DivisionInquiriesAll company or product names mentioned herein are trademarks or registered trademarks of their respective owners. Information provided in this press release is accurate at time of publication and is subject to change without advance notice. Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
More
Fujitsu introduces biometric authentication service for SMBC Nikko Securities Online Trading ACN Newswire

Fujitsu introduces biometric authentication service for SMBC Nikko Securities Online Trading

February 1, 2026
KAWASAKI, Japan, Feb 2, 2026 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited today announced that SMBC Nikko Securities Inc. has adopted Fujitsu's passkey authentication service (FIDO2 standard [1]) for its web services, including online trading for individual customers. This initiative addresses the growing social issue of account hijacking due to unauthorized access. SMBC Nikko Securities will commence operations of this service on January 30, 2026.Passkey authentication leverages biometric authentication and PIN codes, offering superior security against phishing compared to traditional password and two-factor authentication. It also enhances convenience by eliminating the need for password entry and the frustration of forgotten passwords. Fujitsu's online biometric passkey authentication service, part of its Identity and Access Management offering under the Uvance business model, is designed to create a secure authentication environment tailored to customer needs. Being a cloud-based service, it enables rapid and flexible deployment, with SMBC Nikko Securities implementing it in approximately five months.Fujitsu will continue to support SMBC Nikko Securities in further strengthening its security by extending this authentication service to other online services. Additionally, Fujitsu aims to contribute to the establishment of a secure and safe trading environment across the entire financial industry by offering this service to other financial institutions.Under Uvance, Fujitsu's business model to solve societal issues, the company will advance the establishment of secure authentication foundations optimized for customer environments, enhancing authentication and access management across diverse corporate scenarios.OverviewWith the newly introduced Fujitsu authentication service, individual customers of SMBC Nikko Securities will primarily use biometric authentication to log in to online trading websites and transaction apps.Fujitsu's passkey authentication service complies with the FIDO2 standard and is based on public-key cryptography. This ensures that customers' biometric information is not transferred outside their devices, enabling secure biometric authentication. This approach enhances security against phishing and impersonation while maintaining convenience.Fujitsu will promote the adoption of biometric authentication across SMBC Nikko Securities' various web services, thereby strengthening security in line with the guidelines and providing a safe and convenient trading environment.Figure 1: How passkey authentication works Figure 2: Fujitsu’s online biometric passkey authentication serviceBackgroundThe securities industry has seen a surge in cybercrimes such as phishing, unauthorized access, and fraudulent transactions, with 2025 experiencing a particularly sharp increase. In response, in July 2025, the Financial Services Agency in Japan and the Japan Securities Dealers Association published draft guidelines to strengthen security measures for internet trading, calling for the implementation and mandatory use of phishing-resistant multi-factor authentication. While many securities companies currently employ multi-factor authentication combining IDs and passwords with other methods, the risk of breaches by criminal organizations remains. Therefore, there is a demand for more secure solutions, such as passkey authentication.[1] FIDO2:Fast Identity Online. An international standard for online authentication that manages user credentials on the user's device. Passkey authentication complies with this standard.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers around the globe, our 113,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: AI, Computing, Networks, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$23 billion) for the fiscal year ended March 31, 2025 and remains the top digital services company in Japan by market share. Find out more: global.fujitsuPress ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
More

COSMOPlat, Serving 160,000 Firms, Files for Hong Kong IPO on “AI+Industrial Internet” Wave

February 1, 2026
HONG KONG, Feb 2, 2026 - (ACN Newswire via SeaPRwire.com) – On 30 January, COSMOPlat IoT Technology Co., Ltd. ("COSMOPlat" or the "Company") formally commenced its initial public offering (IPO) process in Hong Kong, positioning itself to become the first listed entity in the Hong Kong market focused on the "AI + Industrial Internet" sector. As a leading provider of industrial digitalization and intelligent products and solutions in China, COSMOPlat is dedicated to the deep integration of advanced technologies including Artificial Intelligence (AI), the Internet of Things (IoT), and big data with industrial applications, facilitating high-quality development within the manufacturing industry. The Company has established itself as one of the foremost players in the implementation of industrial solutions, having served over 160,000 enterprise clients to date, including more than 9,500 paying enterprise clients. The Company has successfully assisted clients in establishing 17 Lighthouse Factories.According to Frost & Sullivan, the Company ranked first in China's platform-based industrial data intelligence solutions market by revenue in 2024. Utilizing its proprietary industrial large model-driven COSMOPlat Industrial Internet Platform, the Company has developed a distinctive integrated edge-cloud product and service system, offering both Data Intelligence Solutions and IoT Solutions to its users.The Company has achieved deep integration of AI technology within industrial settings, developing industrial intelligent agents that cover more than 40 core scenarios across three major industries. The number of high-quality intelligent agents has now increased to 57. The Company's enterprise-level industrial internet platform product, COSMO-Sphere, employs a modular architecture. This allows enterprises to flexibly construct their digital infrastructure according to specific requirements, achieving high compatibility and cost-effective deployment.The Company has progressively developed an AI-driven flywheel that operates through four steps: data accumulation, model iteration, intelligent agent deployment and industrial value realization. Furthermore, it has built a comprehensive, full-stack AI technology system encompassing training and inference platforms, large models, and intelligent agent development and application platforms. This continuously strengthens the Company's technological leadership within the industrial digitalization and intelligence landscape. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More

Muyuan Foods IPO: Hog Giant’s Profit Growth Outpaces Top 10 Global Meat Firms, Eyes Global Expansion

February 1, 2026
HONG KONG, Feb 2, 2026 - (ACN Newswire via SeaPRwire.com) – On 29 January, Muyuan Foods Co., Ltd. (“Muyuan Foods” or the “Company”, Stock Code: 2714.HK), a leading enterprise in China’s pork industry, officially launched its share offering. This marks a crucial implementation phase in the Company’s listing process on the Hong Kong Stock Exchange, and also accelerates the implementation of its strategic international layout.As a technology-driven leader in the pork industry, Muyuan Foods has consistently set the pace for the development of the smart hog farming industry. According to Frost & Sullivan, the Company has ranked as the world’s largest hog farming enterprise in terms of both hog production capacity and sales volume since 2021. It has ranked the first globally in terms of hog sales volume for four consecutive years, securing an unassailable leading position in the industry. The continuous growth in the Company’s market share further validates its core competitiveness. Measured by hog sales volume, the Company’s global market share rose steadily from 2.6% in 2021 to 5.6% in 2024. Its market share in 2024 alone exceeded the combined market share of the world’s second to fourth largest industry participants, establishing remarkable scale advantages and industrial influence.Strategic Expansion into Overseas Markets, Vertically-Integrated Business Model Driving Robust Performance GrowthOn the basis of consolidating its leading domestic position and strengthening its development foundation, Muyuan Foods has further formulated its global strategy and actively expanded into overseas markets. Taking the export of technologies and equipment as a core approach, the Company empowers the upgrading of the global hog farming industry and builds an internationalised farming ecosystem. In 2024, the Company entered into a strategic partnership with BAF Vietnam Agriculture Joint Stock Company, providing comprehensive services including hog house design, biosecurity management, odor control solutions and smart hog farming equipment, so as to optimize its hog farming efficiency and ensure environmentally responsible operations, marking a pivotal first step in the Company’s global expansion.Going forward, the Company will continue to replicate its well-proven domestic technology system and cost management expertise to overseas markets with high growth potential. Meanwhile, the Company will integrate high-quality global resources with a global perspective, achieving optimised resource allocation and efficient collaboration. This will further consolidate the Company’s core advantages, enhance its overall competitiveness, continuously expand the boundaries of corporate growth, and support the Company in achieving high-quality global development.In terms of business model, with over 30 years of profound expertise in the hog farming industry, Muyuan Foods has established a vertically-integrated business model covering the entire industrial chain, encompassing hog breeding, hog farming, feed production, as well as slaughtering and meat production. This model not only guarantees the quality of hogs and supply stability from the source, but also effectively hedges against the risks of cyclical fluctuations in the industry through the integration of upstream and downstream industrial chain resources. It has built an inimitable competitive barrier, providing solid support for the Company’s sustained profitability and steady development.At the same time, Muyuan Foods has continuously optimised its operational efficiency by relying on its smart hog farming system, which serves as a core driver for cost reduction and efficiency enhancement. By digitising the Company’s decades of professional hog farming knowledge through intelligent solutions, Muyuan Foods has maintained an industry-leading level in its average annual full cost. Between 2019 and 2024, its cost remained among the lowest of large-scale domestic hog farming enterprises for consecutive years. Furthermore, in the nine months ended 30 September 2025, its cost further decreased to RMB12.19 per kilogram, significantly outperforming the industry average and highlighting its exceptional cost management capabilities.Benefiting from its cutting-edge technologies and superior cost management capabilities, Muyuan Foods has achieved sustained and robust performance growth. From 2014 to 2024, the Company achieved industry-leading revenue growth with a CAGR of 48.7%, representing the highest growth rate among the top ten global listed pork companies by hog sales volume, with a significant lead. During the same period, the Company’s net profit increased at a CAGR of 72.7% and its average annual net profit margin reached 19.0%. Muyuan Foods was the only company to sustain an average annual net profit margin of above 15.0% from 2014 to 2024 among the top ten global listed pork companies, highlighting its outstanding profitability.ESG Performance Recognized by Authoritative Institutions, with Vast Market Offering Ample Space for GrowthAs a pioneer in the green transformation of the industry, Muyuan Foods has consistently and deeply integrated ESG practices into its corporate development strategy. It actively promotes industry best practices to foster the sustainable development of the hog farming industry. The Company implements comprehensive strategies to reduce emissions. Pioneering in adopting renewable energy in China’s hog farming industry, it commenced to use as early as in 2018, replacing traditional energy sources with clean energy to reduce carbon emissions in the production process. Additionally, its proprietary hog houses with fossil fuel-free heating minimize greenhouse gas emissions through precise environmental control, embodying the concept of green farming.Furthermore, Muyuan remains committed to creating lasting social value, contributing to rural revitalization and sustainable agricultural development. The Company vigorously promotes the "integrated crop-livestock cycle" model, transforming farming waste into organic fertilizer. In 2024 alone, it provided high-quality fertilizer support for approximately 4.7 million mu of farmland, conducted 9,293 agricultural technical services, covered 14,482 villages, and directly generated approximately RMB1.4 billion in economic benefits for farmers. By the end of 2024, the Company had cumulatively donated RMB107 million for public welfare projects such as road construction and streetlight installation, achieving a multi-stakeholder win-win outcome of "reducing farming waste, enhancing agricultural efficiency, and revitalizing rural areas".This exceptional ESG performance has gained recognition from authoritative institutions. As of the latest practicable date, according to the latest ESG score from the London Stock Exchange Group (LSEG), Muyuan Foods ranks among the top 20% of 504 global food and tobacco companies. Its emissions score is notably high at 90 out of 100, demonstrating robust environmental management capabilities. Significantly, the Company stands out as a hog farming enterprise within LSEG's top 100 food and tobacco companies for data and analytics, fully showcasing its ESG leadership among global peers.Regarding industry prospects, the global pork consumption market maintains steady growth. According to Frost & Sullivan, global pork consumption increased from 95.20 million tons in 2020 to 115.30 million tons in 2024, achieving a CAGR of 4.9%, indicating strong market demand resilience. As the world's largest pork consumer, China still possesses significant growth potential. In 2024, China's per capita meat consumption was 69.4 kg, compared to 102.0 kg per person in the United States, highlighting considerable room for growth. This offers ample development space for industry leaders like Muyuan Foods.With its leading technological advantages, exceptional cost-control capabilities, advanced ESG practices, and vertically integrated business model across the entire industry chain, Muyuan Foods possesses strong core competitiveness and sustainable development potential. Following the listing in Hong Kong, the Company will further broaden its international financing channels, enhance its global brand influence, accelerate global expansion and scale growth, and continue to lead the industry towards high-quality development. Its long-term growth prospects are worthy of high market expectations. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More

Q4 and FY 2025 production results

February 1, 2026
EQS via SeaPRwire.com / 02/02/2026 / 05:07 MSK Solidcore Resources plc (“Solidcore” or the “Company”) announces production results for the fourth quarter and FY 2025. “Q4 was marked by substantial destockpiling which, together with very favourable gold prices, helped to partially compensate sales disruptions experienced in H1. We expect the remaining inventories to be fully released in 2026. Our projects remain on track: this year will see meaningful progress at our Ertis POX development and the start of construction at Syrymbet, subject to Board approval”, said Vitaly Nesis, CEO of Solidcore Resources plc. HIGHLIGHTS For the fourth consecutive year, there were no lost time injuries recorded among the Company’s employees and contractors. Accordingly, days lost due to work-related injuries (DIS) remained at zero. Full-year (FY) gold equivalent (GE) production totalled 395 Koz, a 19% year-on-year (y-o-y) decrease and 6% below the revised production guidance of 420 Koz, due to delays in Kyzyl concentrate processing at a third-party POX in H1, with more metal inventories carried forward to 2026 than previously expected. As processing stabilised, Q4 production grew by 23% y-o-y and 17% q-o-q to 146 Koz. GE sales in 2025 amounted to 412 Koz and were 23% lower y-o-y due to the production disruptions in H1. Quarterly sales grew by 24% y-o-y to 152 Koz on the back of the metal output recovery in H2. FY revenue increased by 13% to US$ 1.5 billion, driven by higher gold prices, which compensated for the lower sales. Quarterly revenue amounted to US$ 639 million on the back of favourable prices and strong quarterly sales. The Company expects full-year Total Cash Costs (TCC) and All-in Sustaining Cash Costs (AISC) to be approximately 5% above the top end of the guidance range of US$ 1,000-1,100/GE oz and US$ 1,450-1,550/GE oz, due to a higher mining extraction tax (MET) expense. CAPEX is expected to be below the guidance of US$ 300 million at approximately US$ 270 million, as some Ertis POX expenses have been deferred to 2026. Net Cash position as at the end of 2025 stood at US$ 461 million versus net cash of US$ 355 million as at the end of Q3 2025 and US$ 374 mln as at the end of 2024. At Ertis POX, a significant milestone was achieved with the autoclave delivery to the construction site. The project is progressing according to schedule. At Syrymbet, the definitive feasibility study is in progress and the project is moving toward Board approval in H2 2026. In Q4 2025, the Company completed construction of the solar power plant at the Varvara site with the ramp-up expected in H1 2026. The Company will publish its full-year financial results on 19 March 2026. OUTLOOK In 2026, the Company expects to produce с. 540 Koz of GE. The increase will be driven by concentrate inventories release. For 2027, preliminary guidance envisages GE output of c. 500 Koz. 2026 costs are estimated at US$ 1,350-1,550/GE oz for TCC (15-35% increase y-o-y) and US$ 1,850-2,050/GE oz for AISC (15-30% increase y-o-y) subject to the KZT/USD exchange rate, as well as gold price dynamics impacting MET level. The increase relative to 2025 is driven by higher MET expenses – reflecting the introduction of a progressive MET tax rate under the new Tax Code in Kazakhstan, which is linked to gold prices[1] – the effect of higher gold prices, and inflationary pressures. Capital expenditures in 2026 are projected at c. US$ 510 million (almost a twofold increase y-o-y). The y-o-y increase will be driven by higher spending on the Ertis POX construction as the project progresses (US$ 315 million), construction of underground mining infrastructure at Kyzyl, fleet replacement at Varvara hub and the expansion of tailings storage facilities at both Kyzyl and Varvara. In addition to the capital expenditure, the Company will provide a c. US$30 million loan to the Syrymbet JV to finance a feasibility study and other pre-construction costs. PRODUCTION RESULTS 3 months ended Dec 31, % change1 12 months ended Dec 31, % change1 2025 2024 2025 2024 Waste mined, Mt 30.9 33.6 -8% 123.2 129.0 -4% Ore mined (open pit), Kt 1,392 1,512 -8% 5,300 5,201 +2% Ore processed, Kt 1,642 1,618 +1% 6,522 6,372 +2% Average GE grade processed, g/t 2.4 2.5 -4% 2.7 2.8 -2% Mine metal output, GE Koz2 112 122 -8% 508 513 -1% Kyzyl (gold in concentrate) 67 77 -12% 347 343 +1% Varvara 45 45 +0% 161 170 -5% Production, GE Koz3 146 119 +23% 395 490 -19% Kyzyl 101 74 +37% 234 320 -27% Varvara 45 45 +0% 161 170 -5% Sales, GE Koz 152 122 +24% 412 536 -23% Kyzyl 102 80 +27% 240 365 -34% Varvara 50 42 +19% 171 172 -0% Revenue, US$m4, 5 639 322 +99% 1,500 1,327 +13% Net cash/(debt), US$m6 461 355 +30% 461 374 +23% LTIFR7 0 0 NM 0 0 NM DIS (Employees)8 0 0 NM Fatalities Employees 0 0 NM 0 0 NM Contractors 0 0 NM 0 0 NM Average headcount 3,975 3,577 +11% Note: (1) % changes can be different from zero even when absolute numbers are unchanged because of rounding. Likewise, % changes can be equal to zero when absolute numbers differ due to the same reason. This note applies to all tables in this release. (2) Gross metal output generated at the mine site before accounting for third-party refining or processing losses. Based on 80:1 Au/Ag conversion ratio and excluding base metals. Discrepancies in calculations are due to rounding. (3) Represents payable production delivered for final processing or sale to off-takers and with accounting for third-party processing and refining losses. Based on 80:1 Au/Ag conversion ratio and excluding base metals. Discrepancies in calculations are due to rounding. (4) Calculated based on the unaudited consolidated management accounts. (5) Revenue for 2024 includes re-sale of third-party metal. Sales are shown net of re-sale of third-party metal (if applicable). (6) Non-IFRS measure based on unaudited consolidated management accounts. Comparative information is presented for 30 September 2025 (for the three months period) and 31 December 2024 (for the twelve months period). (7) LTIFR = lost time injury frequency rate per 200,000 hours worked and includes only the Company’s own employees. (8) DIS – days lost due to work-related injuries. About Solidcore Solidcore Resources is a leading gold producer registered in AIFC, Kazakhstan, and listed on Astana International Exchange. Solidcore operates two producing gold mines and a major growth project in Kazakhstan. Enquiries Investor Relations Media Kirill Kuznetsov Alina Assanova +7 7172 47 66 55 (Kazakhstan) ir@solidcore-resources.com Yerkin Uderbay +7 7172 47 66 55 (Kazakhstan) media@solidcore-resources.kz FORWARD-LOOKING STATEMENTS This release may include statements that are, or may be deemed to be, “forward-looking statements”. These forward-looking statements speak only as at the date of this release. These forward-looking statements can be identified by the use of forward-looking terminology, including the words “targets”, “believes”, “expects”, “aims”, “intends”, “will”, “may”, “anticipates”, “would”, “could” or “should” or similar expressions or, in each case their negative or other variations or by discussion of strategies, plans, objectives, goals, future events or intentions. These forward-looking statements all include matters that are not historical facts. By their nature, such forward-looking statements involve known and unknown risks, uncertainties and other important factors beyond the company’s control that could cause the actual results, performance or achievements of the company to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding the company’s present and future business strategies and the environment in which the company will operate in the future. Forward-looking statements are not guarantees of future performance. There are many factors that could cause the company’s actual results, performance or achievements to differ materially from those expressed in such forward-looking statements. The company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained herein to reflect any change in the company’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. KYZYL 3 months ended Dec 31, % change 12 months ended Dec 31, % change 2025 2024 2025 2024 MINING Waste mined1, Mt 17.0 19.6 -13% 68.1 80.6 -16% Ore mined (open pit), Kt 594 613 -3% 2,442 2,409 +1% Gold grade, g/t 5.0 5.1 -2% PROCESSING Ore processed, Kt 612 592 +3% 2,470 2,417 +2% Gold grade, g/t 4.0 4.6 -14% 4.9 5.0 -1% Gold recovery 87.0% 87.7% -1% 88.9% 88.6% +0% Concentrate produced, Kt 22.8 27.9 -18% 112.7 118.1 -5% Concentrate gold grade, g/t 92.1 85.6 +8% 95.8 90.4 +6% Gold in concentrate, Koz2 67 77 -12% 347 343 +1% Concentrate shipped to third party smelter, Kt 3 15 -81% 18 55 -68% Payable gold shipped, Koz 6 28 -80% 35 102 -66% Toll-processing at third-party POX Concentrate processed, Kt 32 16 +97% 82 67 +23% Gold grade, g/t 103 103 -0% 102 112 -9% Gold recovery 91.8% 91.4% +0% 92.1% 92.6% -1% Dore produced, Koz 96 46 +109% 199 217 -8% TOTAL PRODUCTION Gold, Koz 101 74 +37% 234 320 -27% Note: (1) Kyzyl waste mined reporting approach was amended to include specification of volume weight coefficients used to convert cubes into tonnes by mines and periods. Previous periods were restated accordingly. (2) Semi-finished material pending sale or final processing is excluded from total production and will be included once shipped to a third-party offtaker or upon doré production under the existing tolling arrangement. In Q4 2025, gold production at Kyzyl increased by 37% y-o-y to 101 Koz, driven by the resumption of processing of the concentrate accumulated in H1 2025 at Amursk POX. However, full-year production declined to 234 Koz due to delays in concentrate deliveries and sales in H1, a trend that is expected to reverse, with production projected to reach 370 koz in 2026. The decline in gold grade in Q4 and the resulting gold in concentrate decrease is attributable to the planned depletion of the high-grade open-pit reserves at the Eastern part of the pit and staged preparation for the underground mining transition. Stripping volumes decreased due to the gradual and systematic reduction of open-pit mining operations. The Company is planning to start underground ore mining in 2030. VARVARA 3 months ended Dec 31, % change 12 months ended Dec 31, % change 2025 2024 2025 2024 MINING Waste mined, Mt 13.9 14.0 -0% 55.2 48.3 +14% Ore mined (open pit), Kt 797 899 -11% 2,858 2,792 +2% Gold grade, g/t 1.4 1.3 +9% PROCESSING Leaching Ore processed, Kt 903 848 +6% 3,396 3,179 +7% Gold grade, g/t 1.4 1.2 +18% 1.3 1.2 +4% Gold recovery1 88.7% 89.4% -1% 90.0% 89.4% +1% Gold production (in Dore), Koz 37 36 +4% 130 129 +1% Flotation Ore processed, Kt 127 178 -29% 657 777 -15% Gold grade, g/t 2.4 2.2 +12% 2.0 2.3 -13% Recovery1 90.6% 88.4% +3% 88.8% 88.9% -0% Gold in concentrate, Koz 7 9 -16% 30 41 -26% TOTAL PRODUCTION Gold, Koz 45 45 +0% 160 170 -5% Note: (1) Technological recovery, includes gold and copper within work-in-progress inventory. Does not include toll-treated ore. At Varvara, quarterly production was stable y-o-y at 45 Koz, while annual volume recorded a 5% y-o-y reduction on the back of the planned decrease in Komar and third-party ore grades during 9M 2025. In Q4, however, higher-grade ore from the deeper levels of the southern part of the Komar pit was introduced into the leaching circuit which resulted in a y-o-y increase in head grade and production. Flotation circuit saw a decrease in quarterly production due to the lower ore processing volumes attributable to the depletion of Varvara high-copper grade ore reserves within the current pit. Flotation plant was mostly processing third-party material with a higher grade, which led to the average grade increase at the circuit. The 11% y-o-y decrease in ore mined in Q4 was driven by the planned involvement of the stockpiled ore into processing. In 2026, the production is projected at 170 Koz. DEVELOPMENT PROJECTS At Ertis POX, the autoclave has been delivered to the construction site and installed on the foundation for temporary storage. Temporary power supply system was installed. Construction of temporary buildings and structures is nearing completion. Public hearings were held and a positive expert conclusion was obtained as part of a report on national Environmental Impact Assessment (EIA). International Environmental and Social Impact Assessment (ESIA) is in its final stage, with the final ESIA report is expected to be finalised in April. In 2026, the Company plans to obtain a positive conclusion from the State Expert Review, complete the installation of foundations for all production and key infrastructure facilities, commence deliveries of the main process equipment, and complete the basic engineering. In parallel, the Company is advancing negotiations with several international banks for loan facilities of US$ 500-600 million and expects to sign the financing agreements in Q2 2026. The Company has completed construction of the 22.6 MW solar power plant at the Varvara site, with ramp up scheduled for early 2026. Construction of the 40 MW gas power plant is proceeding on schedule with the launch expected in 2026. At Syrymbet, an analysis of the design and geological documentation has been carried out. Approximately 60% of the engineering surveys have been completed. Development of the regulatory documentation is ongoing, with completion expected in Q1 2026. The Board of Directors approved a budget of US$ 30 million for site preparation works and the definitive feasibility study. SUSTAINABILITY, HEALTH AND SAFETY During the reporting period, there were no lost time injuries recorded among the Company’s employees and contractors. No days lost due to work-related injuries (DIS) occurred accordingly. 2025 marked 8th consecutive year with no fatal incidents at Solidcore’s operations in Kazakhstan. Safety remains a top priority for Solidcore as we aim to maintain zero fatalities across our operations and among on-site contractors. The Company is committed to implementing initiatives that further enhance health and safety conditions. The Company is actively working on de-risking its energy supply alongside reduction of costs and greenhouse gas (GHG) emissions. In 2026, Solidcore aims to complete construction of the 40 MW gas-piston power plant at Varvara, supporting the transition from purchased grid electricity to self-generated clean energy, resulting in a projected reduction of the Company’s greenhouse gas emissions. In addition, Solidcore plans to continue implementation of its afforestation project in the Kostanay region in 2026, with the planting of approximately 140 ha of new forest, and to launch the second phase of this voluntary forest carbon project covering around 500 ha in the Abay region, near Kyzyl. [1] At US$ 4,000/oz and above the MET rate is at its ceiling of 11%. 02/02/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
More
JCB Launches Usage Promotion Campaign for Inbound Visitors in Fukuoka’s Tenjin Area ACN Newswire

JCB Launches Usage Promotion Campaign for Inbound Visitors in Fukuoka’s Tenjin Area

February 1, 2026
TOKYO, Feb 2, 2026 - (JCN Newswire via SeaPRwire.com) - JCB Co., Ltd. (Headquarters: Minato-ku, Tokyo; Chairman & Chief Executive Officer: Takayoshi Futae; hereinafter: JCB) today announced a promotion campaign for inbound visitors to Japan in the Tenjin area of Fukuoka City, running from February 2 to March 31, 2026. As part of the ongoing business partnership between JCB and American Express in Japan, the campaign is also available to eligible overseas American Express Card Members, including those holding American Express cards issued through partner institutions.JCB and American Express have previously collaborated on initiatives supporting shopping districts and local retailers. In 2025, the two companies conducted a campaign in Kobe City to promote inbound tourism. Building on that success, the new Tenjin campaign invites international visitors to enjoy shopping at participating department stores and retailers popular with tourists.During the campaign period, cardmembers who make a single purchase of 5,000 JPY or more (including tax) using an overseas-issued JCB or American Express card at participating merchants will receive an original Japanese-style drawstring pouch. Prize redemption will be available at an event space directly connected to Tenjin Station, with banners and roll-up displays creating a lively atmosphere. Campaign awareness will further be amplified through announcements on Tenjin Station's large-screen displays and at nearby hotels, encourage shopping.Original Japanese-Style Drawstring Pouch>(JCB) For further details about the event, visit:https://www.specialoffers.jcb/en/campaign/detail/tenjin/91613/>(American Express) For further details about the event, visit:https://www.americanexpress.com/en-sg/business/merchant/explore-japan-with-amex/destination/fukuoka/About JCBJCB is a major global payment brand and a leading credit card issuer and acquirer in Japan. JCB launched its card business in Japan in 1961 and began expanding worldwide in 1981. Its acceptance network includes about 71 million merchants around the world. JCB Cards are now issued mainly in Asian countries and territories, with more than 175 million cardmembers. As part of its international growth strategy, JCB has formed alliances with hundreds of leading banks and financial institutions globally to increase its merchant coverage and cardmember base. As a comprehensive payment solution provider, JCB commits to providing responsive and high-quality service and products to all customers worldwide. For more information, please visit: www.global.jcb/en/ContactAnna TakedaCorporate CommunicationsTel: +81-3-5778-8353Email: jcb-pr@info.jcb.co.jp Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
More
Web-based tool makes it easier to design advanced materials ACN Newswire

Web-based tool makes it easier to design advanced materials

February 1, 2026
TSUKUBA, Japan, Feb 2, 2026 - (ACN Newswire via SeaPRwire.com) - Modern industry relies heavily on catalysts, which are substances that speed up chemical reactions. They’re vital in everything from manufacturing household chemicals to generating clean energy or recycling waste. However, designing new catalysts is challenging because their performance is affected by many interacting factors.A new tool uses a catalyst gene profiling, where catalysts are represented as symbolic sequences, making it easier for scientists to interpret data and design catalysts without a need for programming skills.A new tool developed by researchers at Hokkaido University, published in Science and Technology of Advanced Materials: Methods, will simplify the process by providing researchers with a way to easily view and explore data about catalysts, enabling them to identify patterns and relationships in catalyst datasets without needing advanced programming or computational skills.The tool takes advantage of an approach known as catalyst gene profiling, where catalysts are represented as symbolic sequences. This makes it easier for scientists to interpret the data and apply sequence-based analysis methods to design and improve catalysts. The tool itself is a web-based graphical interface that offers an intuitive and interactive way to investigate these catalyst profiles.“The system enables researchers to explore complex catalyst datasets, identify global trends, and recognize local features—all without requiring advanced programming skills,” explains Professor Keisuke Takahashi, who led the study. “By visualizing both the relationships among catalysts and the underlying gene-based features, the platform makes catalyst design more interpretable, accessible, and efficient, bridging the gap between data-driven analysis and practical experimental insight.”Users can view catalysts clustered together based on how similar their features are or how similar their sequences are. The tool also includes a heat map that offers insights into how the catalyst gene sequences are calculated. The different visualizations can be viewed side by side and are synchronized so they all update simultaneously when a user zooms in or selects a group of catalysts.The team plans to extend the tool to work with other material science datasets so it can be used more broadly in the field. They’re also working to include a predictive component. Integrating modeling and editing strategies would mean researchers could use the tool not only to explore existing catalysts but also to investigate new ideas for high-performance materials. In addition, they want to improve the tool’s collaborative features so that several researchers can work together to explore and annotate datasets, enabling a community-oriented, data-driven approach to material design and discovery.“Our goal is to make advanced materials research more intuitive, approachable, and impactful,” says Takahashi.Further informationKeisuke TakahashiHokkaido University keisuke.takahashi@sci.hokudai.ac.jpPaper: https://doi.org/10.1080/27660400.2025.2600689 About Science and Technology of Advanced Materials: Methods (STAM-M)STAM Methods is an open access sister journal of Science and Technology of Advanced Materials (STAM), and focuses on emergent methods and tools for improving and/or accelerating materials developments, such as methodology, apparatus, instrumentation, modeling, high-through put data collection, materials/process informatics, databases, and programming. https://www.tandfonline.com/STAM-MDr Kazuya SaitoSTAM Methods Publishing Director SAITO.Kazuya@nims.go.jpPress release distributed by Asia Research News for Science and Technology of Advanced Materials. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
TCG.Zone Announces Strategic Pivot to High-Value Collectible Assets ACN Newswire

TCG.Zone Announces Strategic Pivot to High-Value Collectible Assets

February 1, 2026
NEW YORK, Feb 1, 2026 - (ACN Newswire via SeaPRwire.com) - TCG.Zone (The Collectors Grid), a key player in the global collectibles infrastructure and ecosystem, has officially unveiled its strategic shift toward prioritizing investments in high-value, rare collectible assets. This strategic realignment underscores the company’s commitment to tapping into the long-term value and cultural significance of elite collectibles, with the recent participation in a high-profile international auction serving as a pivotal first step in this new direction.Recently, the world's only Pokémon card graded PSA 10 - Pikachu Illustrator - once again became a focal point of global attention across the collectibles and cultural landscape. As a long-term contributor to TCG infrastructure and the broader collectibles ecosystem, The Collectors Grid(TCG.Zone) participated in and witnessed this historically significant moment.Recognized as one of the most iconic works in Pokémon card history, Pikachu Illustrator is distinguished not only by its extreme rarity, but also by its symbolic representation of Pokémon culture, artistic value, and generational memory.The Legendary Status of the World's Only PSA 10According to publicly available information, the world's only PSA 10 "Pikachu Illustrator" card is currently owned by Logan Paul. The card was involved in a high-profile transaction in 2022, valued at nearly USD 5.3 million, marking a defining milestone in the history of Pokémon card collecting.The Industry Significance of Goldin AuctionsAlthough Logan Paul's acquisition of the card did not take place through Goldin, the Goldin auction platform has continued to play an important role in the card's contemporary circulation and visibility. As one of the world's most influential high-end collectibles auction platforms, Goldin's auction framework and the attention it generates brought renewed global focus to this legendary card, further positioning Pokémon cards within the broader mainstream collectibles market.Netflix Documentary Captures a Cultural MomentAmid the phenomenon-level attention generated by this card on the Goldin platform, Netflix documented the full auction process and produced a dedicated documentary. Approached from a cultural and historical perspective, the documentary highlights the unique position of Pikachu Illustrator within the modern collectibles ecosystem, elevating it beyond price alone and framing it as a lasting cultural reference.Global Participation and TCG.Zone's InvolvementThe discussions and auction activity surrounding Pikachu Illustrator attracted participation from top collectors, institutions, and professional teams from around the world. TCG.Zone was among the active participants in the bidding process. During the auction, TCG.Zone submitted a bid of USD 5,000,000. Although the bid was ultimately surpassed by a higher offer, TCG.Zone remained deeply engaged throughout the process and witnessed this pivotal moment firsthand.Continuing to Follow the Card's Future TrajectoryIn post-auction interviews, TCG.Zone stated that this participation does not mark an endpoint. The team will continue to closely monitor the movement and future trajectory of the world's only PSA 10 Pikachu Illustrator, and does not rule out participating again should the right opportunity arise. This event represents more than an auction. It stands as a collective reflection on rarity, cultural identity, and long-term value.The story of Pikachu Illustrator continues to unfold,and remains an enduring chapter in the global history of Pokémon card collecting.About TCGThe Collectors Grid is an on-chain infrastructure designed to formalize collectibles as a structured asset class. By integrating provenance, ownership, pricing, and settlement at the protocol level, it addresses long-standing inefficiencies in the global collectibles market. The platform enables institutional-grade transparency while preserving the unique characteristics of collectible assets. Positioned as a settlement layer rather than a marketplace, The Collectors Grid provides the foundational rails for liquidity, valuation, and long-term capital participation in cards, IP, and high-value collectibles.Social LinksTwitter: https://x.com/tcgzoneofficialInstagram: https://www.instagram.com/tcgzoneofficial/Telegram: https://t.me/tcgzoneofficialMedia ContactBrand : The Collectors Grid (tcg.zone)Contact: AnnieWebsite: https://www.tcg.zone Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
TCG.Zone Participates in a Historic Moment Surrounding the World’s Only PSA 10 ‘Pikachu Illustrator’ SeaPRwire

TCG.Zone Participates in a Historic Moment Surrounding the World’s Only PSA 10 ‘Pikachu Illustrator’

January 31, 2026
New York, NY – February 01, 2026 – (SeaPRwire) – Recently, the world’s only Pokémon card graded PSA 10 – Pikachu Illustrator – once again became a focal point of global attention across the collectibles and cultural landscape. As a long-term contributor to TCG infrastructure and the broader collectibles ecosystem, The Collectors Grid(TCG.Zone) participated in and witnessed this historically significant moment. Recognized as one of the most iconic works in Pokémon card history, Pikachu Illustrator is distinguished not only by its extreme rarity, but also by its symbolic representation of Pokémon culture, artistic value, and generational memory. The Legendary Status of the World’s Only PSA 10 According to publicly available information, the world’s only PSA 10 “Pikachu Illustrator” card is currently owned by Logan Paul. The card was involved in a high-profile transaction in 2022, valued at nearly USD 5.3 million, marking a defining milestone in the history of Pokémon card collecting. The Industry Significance of Goldin Auctions Although Logan Paul’s acquisition of the card did not take place through Goldin, the Goldin auction platform has continued to play an important role in the card’s contemporary circulation and visibility. As one of the world’s most influential high-end collectibles auction platforms, Goldin’s auction framework and the attention it generates brought renewed global focus to this legendary card, further positioning Pokémon cards within the broader mainstream collectibles market. Netflix Documentary Captures a Cultural Moment Amid the phenomenon-level attention generated by this card on the Goldin platform, Netflix documented the full auction process and produced a dedicated documentary. Approached from a cultural and historical perspective, the documentary highlights the unique position of Pikachu Illustrator within the modern collectibles ecosystem, elevating it beyond price alone and framing it as a lasting cultural reference. Global Participation and TCG.Zone’s Involvement The discussions and auction activity surrounding Pikachu Illustrator attracted participation from top collectors, institutions, and professional teams from around the world. TCG.Zone was among the active participants in the bidding process. During the auction, TCG.Zone submitted a bid of USD 5,000,000. Although the bid was ultimately surpassed by a higher offer, TCG.Zone remained deeply engaged throughout the process and witnessed this pivotal moment firsthand. Continuing to Follow the Card’s Future Trajectory In post-auction interviews, TCG.Zone stated that this participation does not mark an endpoint. The team will continue to closely monitor the movement and future trajectory of the world’s only PSA 10 Pikachu Illustrator, and does not rule out participating again should the right opportunity arise. This event represents more than an auction. It stands as a collective reflection on rarity, cultural identity, and long-term value. The story of Pikachu Illustrator continues to unfold,and remains an enduring chapter in the global history of Pokémon card collecting. Social Links Twitter: https://x.com/tcgzoneofficial Instagram: https://www.instagram.com/tcgzoneofficial/ Telegram: https://t.me/tcgzoneofficial Media Contact Brand : The Collectors Grid (tcg.zone) Contact: Annie Email: hi@tcg.zone Website: https://www.tcg.zone
More
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Obtained China NDA Approval, Becoming The First and Only Targeted Drug for Vitiligo in China SeaPRwire

CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Obtained China NDA Approval, Becoming The First and Only Targeted Drug for Vitiligo in China

January 31, 2026
SHENZHEN, Jan 30, 2026 – (ACN Newswire via SeaPRwire.com) – China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited, please refer to the announcement published by the Group on 22 April 2025 for details) received approval from the National Medical Products Administration of China (NMPA) on 30 January 2026 for the New Drug Application (NDA) of ruxolitinib phosphate cream (the “Product”) for the treatment of non-segmental vitiligo with facial involvement in children aged 12 years and older and adult patients. It is the first and only targeted drug approved in China for vitiligo, addressing a significant unmet clinical need. Ruxolitinib phosphate cream is the first and only drug approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for repigmentation in nonsegmental vitiligo[1,2]. Prior to receiving formal NDA approval, the Group benefited from the “Early and Pilot Implementation” policy granted to the Hainan Free Trade Port and Lecheng Pilot Zone (“Lecheng Pilot Zone”), the “Hong Kong and Macau Medicine and Equipment Connect” policy, and the clinically urgently needed imported drug policies of the Beijing and Tianjin Free Trade Zones, and had already initiated the pilot application of ruxolitinib phosphate cream. Currently, Boao Super Hospital has prescribed ruxolitinib phosphate cream to over 7,000 patients with non-segmental vitiligo, and more than twenty hospitals in Guangzhou, Shenzhen, Dongguan, Foshan, Zhongshan, Zhuhai, Jiangmen, Huizhou, Beijing and Tianjin have provided prescription services for the Product, demonstrating its clinical potential. The product has shown positive results in both overseas clinical studies and the real-world study in China: in two identical Phase III double-blind, randomized, placebo-controlled studies (TRuE-V1 and TRuE-V2) conducted overseas, the proportion of patients achieving the primary efficacy endpoint of at least 75% improvement in the Facial Vitiligo Area Score Index (F-VASI 75) after 24 weeks of treatment with ruxolitinib phosphate cream was 29.9% in both studies, significantly higher than the 7.5% and 12.9% in the placebo groups, respectively. Continued use up to 52 weeks showed sustained repigmentation[3]. In accordance with the relevant regulations of the Lecheng Pilot Zone’s real-world data application pilot project, ruxolitinib phosphate cream underwent real-world study in China, demonstrating positive efficacy consistent with the results of overseas pivotal clinical studies. All secondary efficacy endpoints in both domestic and overseas clinical studies showed a benefit trend consistent with the primary efficacy endpoint, and the treatment effect for vitiligo continued to improve with prolonged treatment. Furthermore, according to safety monitoring data from the Lecheng Pilot Zone, no new safety event was identified, no adverse event (AE) leading to discontinuation or withdrawal of treatment occurred, and no study drug-related serious adverse event (SAE) occurred. This approval in vitiligo brings new hope for treatment to over 10 million vitiligo patients in China, addressing urgent clinical needs. At the same time, it will add to Dermavon’s product portfolio in the field of skin treatment, potentially synergizing with Dermavon’s commercialized innovative drug ILUMETRI (tildrakizumab injection), commercialized exclusive drug Hirudoid (mucopolysaccharide polysulfate cream), and a series of innovative drugs under development and dermatological skin care products, in terms of expert network and market resources, thereby potentially enhancing Dermavon’s position in the field of skin health. Furthermore, the Phase III clinical trial in China of ruxolitinib phosphate cream for the treatment of mild to moderate atopic dermatitis (AD) has achieved positive results. Currently, the Group is actively advancing the NDA for ruxolitinib phosphate cream for the treatment of AD in China, which, if approved, will provide a new treatment option for a broader patient population with AD in China. About Vitiligo Vitiligo is a chronic autoimmune disease characterized by depigmentation of the skin, which results from the loss of pigment-producing cells known as melanocytes. It is estimated that there are approximately 10.3 million vitiligo patients in China and non-segmental vitiligo patients account for approximately 8.2 million[4]. Existing therapies, such as topical corticosteroids (TCS) and topical calcineurin inhibitors (TCIs), have clinical limitations, with adverse reactions or limited efficacy with long-term use. The NDA approval of ruxolitinib phosphate cream successfully fills the gap in targeted drug treatment for vitiligo and is of great landmark significance. More About Ruxolitinib Phosphate Cream Ruxolitinib phosphate cream (Opzelura®), a novel cream formulation of the selective JAK1/JAK2 inhibitor ruxolitinib developed by Incyte, is approved for the topical treatment of nonsegmental vitiligo in adult and patients aged 12 years and older, and for the short-term and non-continuous chronic treatment of mild to moderate AD in patients aged 2 years and older without immunodeficiency in the U.S. In Europe, ruxolitinib phosphate cream is approved for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age. The Group, through a subsidiary of Dermavon entered into a Collaboration and License Agreement with Incyte for ruxolitinib phosphate cream on 2 December 2022, obtaining an exclusive license to develop, register and commercialize the Product in Mainland China, Hong Kong Special Administrative Region, Macau Special Administrative Region, Taiwan Region and eleven Southeast Asian countries (the “Territory”) and a non-exclusive license to manufacture the Product in the Territory. The subsidiary of Dermavon has sublicensed the relevant rights for the Product outside Mainland China to the Group (excluding Dermavon and its subsidiary). Incyte has worldwide rights for the development and commercialization of ruxolitinib phosphate cream, marketed in the United States and Europe as Opzelura®. Opzelura® and the Opzelura® logo are registered trademarks of Incyte. About CMS CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs. CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients. CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardio-cerebrovascular/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group. Reference: 1. The U.S. FDA approval information can be found on the Incyte official website, as follows: https://investor.incyte.com/news-releases/news-release-details/incyte-announces-us-fda-approval-opzeluratm-ruxolitinib-cream 2. The EMA approval information can be found on the Incyte official website, as follows: https://investor.incyte.com/news-releases/news-release-details/incyte-announces-european-commission-approval-opzelurar 3. The clinical studies information can be found on the Opzelura® official website, as follows: https://www.opzelura.com/opzelura-prescribing-information 4. China Insights Consultancy’s industrial report CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections. Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/
More
Five Global Megatrends Highlighted at Open Dialogue Expert Forum at the Russia National Centre SeaPRwire

Five Global Megatrends Highlighted at Open Dialogue Expert Forum at the Russia National Centre

January 31, 2026
Moscow, Russia – January 31, 2026 – (SeaPRwire) – Expert Dialogues were held for the first time within the Open Dialogue framework at the Russia National Centre in Moscow on 30 January. The forum focused on five major megatrends shaping global economic, technological, and social development, bringing together international experts to explore how these forces will influence societies and industries in the decades ahead. Organized by the Russia National Centre in partnership with the Centre for Cross-Industry Expertise “The Third Rome” and supported by the Presidential Executive Office, the forum brought together experts from around the world to discuss economic, technological, and social transformations. Maksim Oreshkin, Deputy Head of the Russian Executive Administration for Global Trends, presented five key megatrends that, he said, are already shaping global development and will continue to influence the world in the coming decades. “By 2026, Open Dialogue has become an international platform uniting experts from across the world to discuss the future of the planet, the global economy, and society,” Oreshkin said. “Understanding these processes is essential for preparing for change and leveraging it in the interests of nations and, above all, people. Today, I will focus on five key megatrends — while not treating artificial intelligence as a separate trend, because it has already become an integral part of our lives.” 1. A New Global Economic Paradigm: Globalisation 2.0 A shift from traditional globalisation to a more decentralised system was described. BRICS+ countries now play a growing role in the global economy, technological development, and demographic trends, while the Global South is increasingly engaging in direct trade and national-currency settlements. “Globalisation hasn’t ended; it has changed,” Oreshkin said. “Sovereignty — at state, social, and economic levels — is now the key to competitiveness. Only countries that preserve all three levels can lead in a multipolar world.” China, the USA, India, and Russia are identified as major global powers, while highlighting emerging growth centres such as Indonesia and “connector countries” like the United Arab Emirates. Digital platforms and decentralised networks are also becoming independent participants in the world economy. 2. Platformisation and Institutional Automation The second megatrend highlights the rise of platforms and automation across all sectors. Platforms and algorithms are increasingly shaping decision-making in healthcare, education, finance, trade, and beyond. “Platform solutions enhance efficiency and reduce transaction costs through self-adjusting algorithms,” Oreshkin said. “Countries without technological sovereignty risk becoming dependent on external platforms, which can have strategic consequences during conflicts.” 3. Transformation of the Global Financial System It was noted that traditional financial models face mounting challenges, including rising public debt, widening inequality, and geopolitical fragmentation. Technologies such as blockchain, artificial intelligence, and digital platforms are creating alternative financial mechanisms, including decentralised finance. “The traditional model of cross-border payments is under pressure. Decentralised systems and digital technologies are reshaping the financial system,” he said. 4. Demographic Shifts and Challenges The fourth megatrend concerns global population dynamics. Global fertility rates have fallen sharply, with some countries facing critical declines. By the end of the 21st century, the working-age population may shrink significantly, while the proportion of elderly people rises, placing pressure on pension systems and social services. “Even in Africa, the ratio of elderly to working-age population will rise to 30%, and globally to 56%,” Oreshkin explained. “Education demand will decrease, but healthcare and social service needs will grow. These interconnected trends will amplify each other.” 5. Human Capital Development in the Technological Era The final megatrend focuses on human capital in a rapidly changing technological environment. Autonomous systems, digital platforms, and artificial intelligence are transforming education, work, and healthcare, while biotechnologies expand human capabilities. “AI is both a challenge and an opportunity,” Oreshkin said. “It allows personalized learning paths and supports teachers. Professions are changing: mid-level specialists will be in demand, and companies must retrain employees from junior positions. The social sphere will also evolve, ensuring active longevity in the new demographic era.” Global Perspective Throughout the presentation, Oreshkin illustrated each trend with real-life examples from different continents: a manager from Asia, a farmer from Africa, and a homemaker from Eastern Europe. He highlighted that innovations in Africa could improve education and healthcare, Eastern Europe may see rising living standards and more efficient social systems, and Asia will require reskilling to meet changing labor demands. “The world has entered a period of significant change in finance, demography, and other spheres. States, companies, and individuals must be prepared. Those who understand and adapt will shape the future,” Oreshkin concluded. Open Dialogue on Air This year, Open Dialogue introduced a podcast format — Open Dialogue on Air — featuring global experts discussing key trends in international development. Participants include award-winning Chinese sci-fi writer Chen Qiufan, Dr. Selina Neri of the Future Readiness Academy, Dr. Rais Hussin of EMIR Research (Malaysia), Prof. Wang Feng of UC Irvine, and global strategist Dr. Parag Khanna. First held in April 2025 at the Russia National Centre, the Open Dialogue brought together over 3,000 experts from dozens of countries. By presidential decree, it will now be held annually. Social Links Telegram: https://t.me/gowithrussia VK: https://vk.com/gowithrussia OK: https://ok.ru/gowithrussia DZen: https://dzen.ru/gowithrussia Contact for the media Brand: Russia National Centre Contact: Media team Email: Pressa@russia.ru Website: https://russia.ru Essay Submission: https://dialog.russia.ru/en/
More
Five Global Megatrends Highlighted at Open Dialogue Expert Forum at the Russia National Centre ACN Newswire

Five Global Megatrends Highlighted at Open Dialogue Expert Forum at the Russia National Centre

January 31, 2026
MOSCOW, Jan 31, 2026 - (ACN Newswire via SeaPRwire.com) - Expert Dialogues were held for the first time within the Open Dialogue framework at the Russia National Centre in Moscow on 30 January. The forum focused on five major megatrends shaping global economic, technological, and social development, bringing together international experts to explore how these forces will influence societies and industries in the decades ahead.Organized by the Russia National Centre in partnership with the Centre for Cross-Industry Expertise "The Third Rome" and supported by the Presidential Executive Office, the forum brought together experts from around the world to discuss economic, technological, and social transformations.Maksim Oreshkin, Deputy Head of the Russian Executive Administration for Global Trends, presented five key megatrends that, he said, are already shaping global development and will continue to influence the world in the coming decades."By 2026, Open Dialogue has become an international platform uniting experts from across the world to discuss the future of the planet, the global economy, and society," Oreshkin said. "Understanding these processes is essential for preparing for change and leveraging it in the interests of nations and, above all, people. Today, I will focus on five key megatrends — while not treating artificial intelligence as a separate trend, because it has already become an integral part of our lives."1. A New Global Economic Paradigm: Globalisation 2.0A shift from traditional globalisation to a more decentralised system was described. BRICS+ countries now play a growing role in the global economy, technological development, and demographic trends, while the Global South is increasingly engaging in direct trade and national-currency settlements."Globalisation hasn't ended; it has changed," Oreshkin said. "Sovereignty — at state, social, and economic levels — is now the key to competitiveness. Only countries that preserve all three levels can lead in a multipolar world."China, the USA, India, and Russia are identified as major global powers, while highlighting emerging growth centres such as Indonesia and "connector countries" like the United Arab Emirates. Digital platforms and decentralised networks are also becoming independent participants in the world economy.2. Platformisation and Institutional AutomationThe second megatrend highlights the rise of platforms and automation across all sectors. Platforms and algorithms are increasingly shaping decision-making in healthcare, education, finance, trade, and beyond."Platform solutions enhance efficiency and reduce transaction costs through self-adjusting algorithms," Oreshkin said. "Countries without technological sovereignty risk becoming dependent on external platforms, which can have strategic consequences during conflicts."3. Transformation of the Global Financial SystemIt was noted that traditional financial models face mounting challenges, including rising public debt, widening inequality, and geopolitical fragmentation. Technologies such as blockchain, artificial intelligence, and digital platforms are creating alternative financial mechanisms, including decentralised finance."The traditional model of cross-border payments is under pressure. Decentralised systems and digital technologies are reshaping the financial system," he said.4. Demographic Shifts and ChallengesThe fourth megatrend concerns global population dynamics. Global fertility rates have fallen sharply, with some countries facing critical declines. By the end of the 21st century, the working-age population may shrink significantly, while the proportion of elderly people rises, placing pressure on pension systems and social services."Even in Africa, the ratio of elderly to working-age population will rise to 30%, and globally to 56%," Oreshkin explained. "Education demand will decrease, but healthcare and social service needs will grow. These interconnected trends will amplify each other."5. Human Capital Development in the Technological EraThe final megatrend focuses on human capital in a rapidly changing technological environment.Autonomous systems, digital platforms, and artificial intelligence are transforming education, work, and healthcare, while biotechnologies expand human capabilities."AI is both a challenge and an opportunity," Oreshkin said. "It allows personalized learning paths and supports teachers.Professions are changing: mid-level specialists will be in demand, and companies must retrain employees from junior positions. The social sphere will also evolve, ensuring active longevity in the new demographic era."Global PerspectiveThroughout the presentation, Oreshkin illustrated each trend with real-life examples from different continents: a manager from Asia, a farmer from Africa, and a homemaker from Eastern Europe. He highlighted that innovations in Africa could improve education and healthcare, Eastern Europe may see rising living standards and more efficient social systems, and Asia will require reskilling to meet changing labor demands."The world has entered a period of significant change in finance, demography, and other spheres. States, companies, and individuals must be prepared. Those who understand and adapt will shape the future," Oreshkin concluded.Open Dialogue on AirThis year, Open Dialogue introduced a podcast format — Open Dialogue on Air — featuring global experts discussing key trends in international development. Participants include award-winning Chinese sci-fi writer Chen Qiufan, Dr. Selina Neri of the Future Readiness Academy, Dr. Rais Hussin of EMIR Research (Malaysia), Prof. Wang Feng of UC Irvine, and global strategist Dr. Parag Khanna.First held in April 2025 at the Russia National Centre, the Open Dialogue brought together over 3,000 experts from dozens of countries. By presidential decree, it will now be held annually.Social LinksTelegram: https://t.me/gowithrussiaVK: https://vk.com/gowithrussiaOK: https://ok.ru/gowithrussiaDZen: https://dzen.ru/gowithrussiaContact for the mediaBrand: Russia National CentreContact: Media teamEmail: Pressa@russia.ru Website: https://russia.ruEssay Submission: https://dialog.russia.ru/en/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
NTT DOCOMO Concludes Partnership Agreement with Aduna to Advance Global Network API Expansion ACN Newswire

NTT DOCOMO Concludes Partnership Agreement with Aduna to Advance Global Network API Expansion

January 30, 2026
TOKYO, Japan, Jan 30, 2026 - (JCN Newswire via SeaPRwire.com) - NTT DOCOMO, INC. and Aduna announced today that they concluded a partnership agreement (the “Agreement”) on January 29, 2026. This partnership enables DOCOMO's network Application Programming Interfaces (network APIs), developed for the international markets, to be made available through Aduna's platform. Together, the companies aim to accelerate the expansion of the global network API ecosystem in response to evolving industry demand.Providing mobile network capabilities through APIs has been gaining traction globally as an effective way for enterprises to address critical issues such as fraud prevention and secure digital authentication. Supported by the CAMARA*1 framework, Mobile Network Operators are developing and exposing standardized API solutions that address critical security needs. Aduna-acting as the global aggregator*2 for these standardized APIs-provides a single, centralized access point to multiple operators worldwide, helping to accelerate ecosystem adoption and simplify enterprise integration at scale.As part of its efforts to generate new revenue streams, DOCOMO has participated in the GSMA Open Gateway*3 initiative and, since June 2025, has been collaborating with Aduna to expand network API-based services through aggregation model.Through the Agreement, DOCOMO's advanced network APIs are expected to become accessible to enterprises and developers worldwide via Aduna's global platform. This collaboration aims to support fraud prevention strategies via APIs such as Number Verification and SIM Swap detection, thus enabling enterprises to protect customers from account takeovers, identity theft, and mobile fraud. The partnership also opens up additional routes for DOCOMO to reach new customer segments through global distribution.Leveraging DOCOMO's innovation and Aduna's global aggregation and distribution model, the companies intend to support broader adoption of network APIs and enable enterprises and developers to create new, value-driven services.Nobuko Hiraguchi, Senior Vice President and General Manager of the Core Network Design Department at NTT DOCOMO, commented: “We are delighted to enter into this partnership agreement with Aduna. By making NTT DOCOMO's network APIs-developed in alignment with global standards-available through Aduna's global platform, we are confident that this collaboration will help create new value that enhances the safety and comfort of each customer's daily life. NTT DOCOMO will continue to advance technical development, including network APIs, to deliver even greater value to society and our customers.”Anthony Bartolo, CEO of Aduna, commented: “Aduna was founded to help telecom operators such as DOCOMO transform standardization into real commercial value. By linking DOCOMO's advanced network APIs to a global distribution platform, we enable enterprises worldwide to innovate more quickly, securely, and at scale. This partnership strengthens Aduna's presence across the Asia region and reflects our shared commitment to accelerating the growth of the global Network API economy.”*1 The CAMARA Project is an open-source project under the Linux Foundation that develops common specifications for operator network APIs.*2 An aggregator is an entity that enables enterprises and developers to access standardized network APIs-offered by multiple mobile network operators-through a single unified platform.*3 GSMA Open Gateway is a global industry initiative launched by the GSMA to promote the commercialization of common network APIs across mobile operators.About NTT DOCOMONTT DOCOMO, Japan's leading mobile operator with over 91 million subscribers, is one of the global leaders in 3G, 4G and 5G mobile network technologies. Under the slogan “Bridging Worlds for Wonder & Happiness,” DOCOMO is actively collaborating with global partners to expand its business scope from mobile services to comprehensive solutions, aiming to deliver unsurpassed value and drive innovation in technology and communications, ultimately to support positive change and advancement in global society. https://www.docomo.ne.jp/english/About AdunaAduna is a landmark venture between some of the world's leading telecom operators and Ericsson, dedicated to enabling developers worldwide to accelerate innovation by leveraging networks to their full potential via common network Application Programming Interfaces (APIs). Its venture partners include AT&T, Bharti Airtel, Deutsche Telekom, KDDI, Orange, Reliance Jio, Singtel, Telefonica, Telstra, T-Mobile, Verizon, and Vodafone. Aduna's developer partner platforms include Google Cloud, Infobip, Sinch, and Vonage. By combining network APIs from multiple operators globally under a unified platform based on the CAMARA open-source project, driven by the GSMA and the Linux Foundation, Aduna provides a standardized platform to foster collaboration, enhance user experiences, and drive industry growth. To find out more about network APIs and Aduna, visit https://adunaglobal.com/. Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
More
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Obtained China NDA Approval, Becoming The First and Only Targeted Drug for Vitiligo in China ACN Newswire

CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Obtained China NDA Approval, Becoming The First and Only Targeted Drug for Vitiligo in China

January 30, 2026
SHENZHEN, Jan 30, 2026 - (ACN Newswire via SeaPRwire.com) - China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited, please refer to the announcement published by the Group on 22 April 2025 for details) received approval from the National Medical Products Administration of China (NMPA) on 30 January 2026 for the New Drug Application (NDA) of ruxolitinib phosphate cream (the “Product”) for the treatment of non-segmental vitiligo with facial involvement in children aged 12 years and older and adult patients. It is the first and only targeted drug approved in China for vitiligo, addressing a significant unmet clinical need.Ruxolitinib phosphate cream is the first and only drug approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for repigmentation in nonsegmental vitiligo[1,2]. Prior to receiving formal NDA approval, the Group benefited from the “Early and Pilot Implementation” policy granted to the Hainan Free Trade Port and Lecheng Pilot Zone (“Lecheng Pilot Zone”), the “Hong Kong and Macau Medicine and Equipment Connect” policy, and the clinically urgently needed imported drug policies of the Beijing and Tianjin Free Trade Zones, and had already initiated the pilot application of ruxolitinib phosphate cream. Currently, Boao Super Hospital has prescribed ruxolitinib phosphate cream to over 7,000 patients with non-segmental vitiligo, and more than twenty hospitals in Guangzhou, Shenzhen, Dongguan, Foshan, Zhongshan, Zhuhai, Jiangmen, Huizhou, Beijing and Tianjin have provided prescription services for the Product, demonstrating its clinical potential.The product has shown positive results in both overseas clinical studies and the real-world study in China: in two identical Phase III double-blind, randomized, placebo-controlled studies (TRuE-V1 and TRuE-V2) conducted overseas, the proportion of patients achieving the primary efficacy endpoint of at least 75% improvement in the Facial Vitiligo Area Score Index (F-VASI 75) after 24 weeks of treatment with ruxolitinib phosphate cream was 29.9% in both studies, significantly higher than the 7.5% and 12.9% in the placebo groups, respectively. Continued use up to 52 weeks showed sustained repigmentation[3]. In accordance with the relevant regulations of the Lecheng Pilot Zone's real-world data application pilot project, ruxolitinib phosphate cream underwent real-world study in China, demonstrating positive efficacy consistent with the results of overseas pivotal clinical studies. All secondary efficacy endpoints in both domestic and overseas clinical studies showed a benefit trend consistent with the primary efficacy endpoint, and the treatment effect for vitiligo continued to improve with prolonged treatment. Furthermore, according to safety monitoring data from the Lecheng Pilot Zone, no new safety event was identified, no adverse event (AE) leading to discontinuation or withdrawal of treatment occurred, and no study drug-related serious adverse event (SAE) occurred.This approval in vitiligo brings new hope for treatment to over 10 million vitiligo patients in China, addressing urgent clinical needs. At the same time, it will add to Dermavon’s product portfolio in the field of skin treatment, potentially synergizing with Dermavon’s commercialized innovative drug ILUMETRI (tildrakizumab injection), commercialized exclusive drug Hirudoid (mucopolysaccharide polysulfate cream), and a series of innovative drugs under development and dermatological skin care products, in terms of expert network and market resources, thereby potentially enhancing Dermavon's position in the field of skin health.Furthermore, the Phase III clinical trial in China of ruxolitinib phosphate cream for the treatment of mild to moderate atopic dermatitis (AD) has achieved positive results. Currently, the Group is actively advancing the NDA for ruxolitinib phosphate cream for the treatment of AD in China, which, if approved, will provide a new treatment option for a broader patient population with AD in China.About VitiligoVitiligo is a chronic autoimmune disease characterized by depigmentation of the skin, which results from the loss of pigment-producing cells known as melanocytes. It is estimated that there are approximately 10.3 million vitiligo patients in China and non-segmental vitiligo patients account for approximately 8.2 million[4]. Existing therapies, such as topical corticosteroids (TCS) and topical calcineurin inhibitors (TCIs), have clinical limitations, with adverse reactions or limited efficacy with long-term use. The NDA approval of ruxolitinib phosphate cream successfully fills the gap in targeted drug treatment for vitiligo and is of great landmark significance.More About Ruxolitinib Phosphate CreamRuxolitinib phosphate cream (Opzelura®), a novel cream formulation of the selective JAK1/JAK2 inhibitor ruxolitinib developed by Incyte, is approved for the topical treatment of nonsegmental vitiligo in adult and patients aged 12 years and older, and for the short-term and non-continuous chronic treatment of mild to moderate AD in patients aged 2 years and older without immunodeficiency in the U.S. In Europe, ruxolitinib phosphate cream is approved for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age.The Group, through a subsidiary of Dermavon entered into a Collaboration and License Agreement with Incyte for ruxolitinib phosphate cream on 2 December 2022, obtaining an exclusive license to develop, register and commercialize the Product in Mainland China, Hong Kong Special Administrative Region, Macau Special Administrative Region, Taiwan Region and eleven Southeast Asian countries (the “Territory”) and a non-exclusive license to manufacture the Product in the Territory. The subsidiary of Dermavon has sublicensed the relevant rights for the Product outside Mainland China to the Group (excluding Dermavon and its subsidiary).Incyte has worldwide rights for the development and commercialization of ruxolitinib phosphate cream, marketed in the United States and Europe as Opzelura®. Opzelura® and the Opzelura® logo are registered trademarks of Incyte.About CMSCMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardio-cerebrovascular/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.Reference:1. The U.S. FDA approval information can be found on the Incyte official website, as follows:https://investor.incyte.com/news-releases/news-release-details/incyte-announces-us-fda-approval-opzeluratm-ruxolitinib-cream2. The EMA approval information can be found on the Incyte official website, as follows:https://investor.incyte.com/news-releases/news-release-details/incyte-announces-european-commission-approval-opzelurar3. The clinical studies information can be found on the Opzelura® official website, as follows:https://www.opzelura.com/opzelura-prescribing-information4. China Insights Consultancy’s industrial reportCMS Disclaimer and Forward-Looking StatementsThis press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More

SuperX Commences Production at First Global Supply Center

January 30, 2026
OSAKA, Japan, January 30, 2026 - (ACN Newswire via SeaPRwire.com) - SuperX AI Technology Limited (NASDAQ: SUPX) ("the Company" or "SuperX"), an emerging AI Data Center infrastructure solutions provider, today announced the official start of production at its newly established SuperX Global Supply Center in Japan. Located in Tsu City, Mie Prefecture, Japan, this facility represents SuperX’s primary supply hub. The commencement of production at this facility marks the Company's transition from engineering and preparation to scaled commercial production. Located in Japan, this center is established to serve SuperX’s global customer base.Strategic Rationale & Operational FocusSuperX selected Japan for its first supply center to integrate Japan’s established industrial capabilities with SuperX’s technical expertise. The center focuses on three pragmatic objectives:Manufacturing Quality: Leveraging Japan’s rigorous execution standards to ensure high reliability for high-performance AI servers.Production Scale: The facility is currently capable of delivering up to 20,000 AI servers annually, providing the capacity needed to fulfill immediate demand, and expandable to fulfil future global orders.Global Export: Serving as a consolidated hub for system integration and logistics, streamlining delivery to international markets.Market ProgressThe commencement of production at the SuperX Global Supply Center supports the Company’s immediate commercial execution. In January, 2026, SuperX has secured customer purchase orders with an estimated total value of USD 910 million. Separately, the Company has also entered into MOUs with several potential customers for the purchase of 5,000 units of AI servers within the next 12 months, with an estimated total order value of up to USD 2.1 billion.Globalized Support ServicesTo better support customers through AI server product deployment and post-sales services, SuperX is rolling out a standardized technical service system, including 24/7 response via a global support center based in Singapore, expert-level technical support, and end-to-end services. For domestic Japanese delivery and operations, SuperX combines a global technical team with a local spare-parts network. This enables customizable project implementation services, and tiered SLA-backed on-site maintenance options to support rapid go-live and stable operation. Executive Commentary"This is a foundational moment for SuperX," said Dr. Chenhong Huang, Chairman and CEO of SuperX. "By establishing our first SuperX Global Supply Center in Japan, we are securing the engineering discipline and quality assurance required to compete on a global stage. This facility allows us to control our production standards and deliver reliable, full-stack AI solutions to our customers worldwide."About SuperX AI Technology Limited (NASDAQ: SUPX) SuperX AI Technology Limited is an AI infrastructure solutions provider, offering a comprehensive portfolio of proprietary hardware, advanced software, and end-to-end services for AI data centers. The Company's services include advanced solution design and planning, cost-effective infrastructure product integration, and end-to-end operations and maintenance. Its core products include high-performance AI servers, 800 Volts Direct Current (800VDC) solutions, high-density liquid cooling solutions, as well as AI cloud and AI agents. Headquartered in-Singapore, the Company serves institutional clients globally, including enterprises, research institutions, and cloud and edge computing deployments. For more information, please visit:www.superx.sg Safe Harbor Statement This press release may contain forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The reader is cautioned not to rely on these forward-looking statements. The forward-looking events discussed in this press release, including quantities and estimated value of orders and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. The quantities and estimated order value mentioned in the MOUsA are non-binding and subject to the execution of purchase orders and definitive agreements . Actual delivery schedules and value of AI servers may vary based on customer data center readiness and supply chain conditions. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur. Follow our social media: X.com:https://x.com/SUPERX_AI_ LinkedIn:https://www.linkedin.com/company/superx-ai Facebook:https://www.facebook.com/people/Super-X-AI-Technology-Limited/61578918040072/# Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
From Digitization to AI Computing: Cheche Group Inc. (CCG) Partners with Volkswagen DSSO and Cardif Airstar Insurance to Usher in the “Premium Era” of Advanced Smart Driving Insurance ACN Newswire

From Digitization to AI Computing: Cheche Group Inc. (CCG) Partners with Volkswagen DSSO and Cardif Airstar Insurance to Usher in the “Premium Era” of Advanced Smart Driving Insurance

January 30, 2026
HONG KONG, January 30, 2026 - (ACN Newswire via SeaPRwire.com) – As China’s first batch of Level 3 (L3) conditionally autonomous driving vehicles receives official market access, advanced smart driving is poised for its inaugural year of commercial explosion. At this pivotal juncture, Cheche Group Inc. (CCG) ("Cheche" or the "Company"), a leading global InsurTech platform, announced the signing of a strategic cooperation agreement with Volkswagen (Anhui) Digital Sales and Services Co., Ltd. (hereinafter "DSSO") and Beijing Cardif Airstar Property & Casualty Insurance Co., Ltd. (hereinafter "Cardif Airstar Insurance").This tripartite collaboration is more than just a deep dive into high-quality growth for New Energy Vehicle (NEV) insurance; it represents a core transition from "digitization" to "intelligence." The partnership establishes three strategic directions for synergy. First, it focuses on the transformation of product formats by leveraging Cheche’s SaaS platform to co-create an integrated "Insurance + Value-Added Services" package, enabling the efficient, one-stop fulfillment of high-value services. Second, it upgrades pricing capabilities by deeply integrating compliant driving data with dynamic vehicle information, utilizing AI-driven risk profiling to achieve differentiated precision pricing while addressing the complex challenge of liability determination in human-machine co-driving scenarios. Finally, it expands the ecosystem dimension by embedding insurance services throughout the vehicle sales and after-sales process, extending the business from a single policy to a full-lifecycle service ecosystem that encompasses renewal management and mobility protection.01. Smart Driving Insurance: Securing "Pricing Authority" in the L3 Mass Production EraTraditional auto insurance has long struggled with "human-machine co-driving" scenarios due to a lack of real-time dynamic data for liability determination and precise risk identification. Having served leading automakers such as Tesla, Li Auto, and Xiaomi, Cheche provides VW Anhui Digital with an embedded SaaS system centered on data attribution and dynamic pricing.Through this SaaS infrastructure, vehicle driving data is seamlessly synchronized with BNP Paribas Star’s actuarial models. This AI-driven joint risk profiling not only resolves the technical difficulties of liability judgment in smart driving scenarios but also delivers a "low-premium rewards for safe drivers," serving as a vital solution to the profitability challenges currently facing the NEV insurance industry.02. Ecosystem Breakthrough: Leveraging the "Xiaomi + Volkswagen DSSO" New Quality Productive ForcesInvestors are closely watching the cross-sector dynamics underpinning this collaboration. Cardif Airstar Insurance was co-founded by Xiaomi Group, Volkswagen Financial Services, and Cardif Airstar Insurance, combining the strengths of an internet giant, a global financial powerhouse, and a leading smart automaker.As the hub connecting these forces with Volkswagen’s Hefei Intelligent Electric Vehicle Center, Cheche is penetrating the world’s top smart driving supply chains. This is not merely system integration; it marks Cheche’s evolution into a digital operator within the "Vehicle-Battery-Charging-Insurance" integrated landscape. Amid policy tailwinds such as "New Quality Productive Forces," Cheche’s closed-loop ecosystem is becoming a definitive growth pole for insurance and tech capital.03. Scenario Transformation: From Transactional Policies to Full-Lifecycle OperationsIn 2026, as the automotive market shifts from a competition over hardware parameters to a competition over user experience, Cheche is helping DSSO deeply couple insurance services with the car-buying and after-sales journey. The integrated service package transforms insurance from a low-frequency tool into a high-frequency touchpoint for user engagement.Christian Koenig, After-sales Director of DSSO, noted that Cheche’s technical foundation allowed the partnership to advance rapidly from a high starting point. This "plug-and-play" empowerment capability, proven by mainstream automakers, has become a technical moat for Cheche in the capital markets.04. Conclusion: The Final Piece of the Trillion-Dollar Blue OceanThe year 2026 marks the point where NEV insurance evolves from scale expansion to intelligent upgrades. Cheche will continue to advance its AI pricing engine, driving the leap from digital to intelligent services.According to data released by the Ministry of Public Security on January 26, China’s NEV ownership reached 43.97 million units by the end of 2025, accounting for 12.01% of the total vehicle population—a growth rate exceeding 40% year-over-year. In this environment, those who define the insurance standards for the smart driving era will control the entry point to future mobility. With its high barriers to entry via OEM partnerships and forward-looking AI layouts, Cheche is racing toward becoming a leader in the trillion-dollar NEV insurance market. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Nissin Foods (Hong Kong) Charity Fund Supports Elite Athletes from The Education University of Hong Kong for the Fourth Consecutive Year ACN Newswire

Nissin Foods (Hong Kong) Charity Fund Supports Elite Athletes from The Education University of Hong Kong for the Fourth Consecutive Year

January 30, 2026
HONG KONG, January 30, 2026 - (ACN Newswire via SeaPRwire.com) – 27 January 2026, Nissin Foods (Hong Kong) Charity Fund (“Charity Fund”) announced its continued support for elite athletes from The Education University of Hong Kong (“EdUHK”) for the fourth consecutive year. The Presentation Ceremony for the Nissin Foods Scholarship for Elite Athletes 2025/2026 was held to honour seven outstanding athletes who not only demonstrate excellence in their respective sports but also aspire to become future educators. The scholarship will cover their full tuition fees throughout their entire study period, enabling them to pursue their academic and athletic goals without financial concerns.Established in 2022 by the Nissin Foods (Hong Kong) Charity Fund, the scholarship is designed to encourage elite athletes enrolled in the Bachelor of Health Education (Honours), Bachelor of Science (Honours) in Sports Science and Coaching, or the Postgraduate Diploma in Education programme at EdUHK. The initiative aims to support their dual career development, empowering them to become qualified health educators while continuing to strive for excellence in their athletic performance.The seven awardees for the 2025/2026 academic year include new and renewing recipients. The four new awardees are: Mr. MOK Pak Fan (triathlon), Mr. WONG Pak Yiu (triathlon), Miss HO Kin Yiu (volleyball), and Miss YAN Nuo (shuttlecock). In addition to welcoming new scholars, the Charity Fund also made the scholarship renewable to support the elite athletes throughout their study period. The three recipients of the renewed scholarship are: Mr. CHOI Kwan Lok (cycling, retired), Mr. CHEN Pak Hong (rowing), and Mr. Joseph LAU (cycling).Mr. Kiyotaka ANDO, Chairman of Nissin Foods (Hong Kong) Charity Fund, said, “Having been deeply rooted in Hong Kong for over four decades, Nissin Foods is steadfast in its mission to give back to the community. This scholarship is a direct reflection of our founder Mr. Momofuku Ando’s philosophy that ‘Eating and sports are the two axles of health.’ By supporting these talented athletes at EdUHK for the fourth year, we are not just providing financial support, we are investing in future leaders who will champion health and wellness in our society. We are proud to empower them on their dual career path, confident that they will inspire the next generation as both accomplished athletes and dedicated educators.”Expressing his profound gratitude for the long-standing partnership, Professor Chetwyn CHAN, Vice President (Research and Development) of EdUHK, said, “EdUHK is dedicated to promoting sustainable dual-career pathways for high-performance athletes. The generous Nissin Foods Scholarship for Elite Athletes allows us to support both active and retired athletes in advancing their educational pursuits, while also recognising their exceptional sporting accomplishments. I would like to extend my heartfelt congratulations to all the scholarship recipients, who demonstrated great passion, determination, and a sense of mission, and sincerely thank the Nissin Foods (Hong Kong) Charity Fund, and Mr Ando for the tremendous support and confidence in health education and the development of elite athletes.”Accomplished volleyball player Miss HO Kin Yiu, recipient of the scholarship from the Postgraduate Diploma in Education, majoring in Chinese and Physical Education, shared her heartfelt appreciation to the Charity Fund, “The support of the scholarship empowers us, as elite athlete-students, to chase our aspirations and make a meaningful influence on society. We are confident that we can help create a brighter future through the spirit of sports and education.”PhotoMr. Kiyotaka ANDO, Chairman of Nissin Foods (Hong Kong) Charity Fund (middle right), and Professor Chetwyn CHAN, Vice President (Research and Development) of EdUHK (middle left), attended the Presentation Ceremony for Nissin Foods Scholarship for Elite Athletes 2025/2026 on 27 January 2026. Five scholarship recipients attended the ceremony, including four new awardees for the 2025/2026 academic year, namely: (from left to right) Mr. MOK Pak Fan, Mr. WONG Pak Yiu, Miss HO Kin Yiu, and Miss YAN Nuo, as well as the renewed awardee - Mr. CHOI Kwan Lok. Awardees of the Nissin Foods Scholarship for Elite Athletes 2025/2026 are achieving great success in their individual disciplines. From top left: Mr. WONG Pak Yiu (triathlon), Miss HO Kin Yiu (volleyball), Mr. MOK Pak Fan (triathlon), Miss YAN Nuo (shuttlecock), Mr. CHOI Kwan Lok (cycling, retired), Mr. CHEN Pak Hong (rowing), and Mr. Joseph LAU (cycling).About Nissin Foods (Hong Kong) Charity FundThe Nissin Foods (Hong Kong) Charity Fund (“Charity Fund”) was set up in September 2020 by way of a trust deed by Nissin Foods Company Limited (Stock code: 1475). The objectives of the Charity Fund are: a) to advance education, teaching, learning, arts, science and academic research; b) to make provision for people in need; and c) to carry out works of a charitable nature that are beneficial to the Hong Kong community. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More

China Unicom Attains the China Securities ‘Golden Bauhinia Awards’

January 29, 2026
EQS via SeaPRwire.com / 30/01/2026 / 15:29 UTC+8 Hong Kong, 30 January 2026 – On 30 January 2026, the 15th Hong Kong International Financial Forum and China Securities "Golden Bauhinia Awards" Ceremony, co-hosted by Hong Kong Ta Kung Wen Wei Media Group, Hong Kong Chinese Enterprises Association, Chinese Financial Association of Hong Kong, Chinese Securities Association of Hong Kong, and Hong Kong Chartered Governance Institute, was grandly held in Hong Kong. The event is a publicly recognised selection with extensive influence in the capital markets of Chinese Mainland and Hong Kong. China Unicom (Hong Kong) Limited (HKEx: 762) has been honored with two awards: "Best Listed Company" and "Best Investor Relations Listed Company". Mr. Chen Shuxiong, President of China Unicom (Hong Kong) Limited Hong Kong Headquarter, accepted the awards on behalf of the Company. These awards reflect the capital market’s recognition of the Company’s performance over the past year in areas including market capitalisation performance, investor relations, information disclosure, corporate governance, and environmental, social and governance (ESG) practices. As an important platform for documenting industrial transformation and fostering communication between the capital markets of Chinese Mainland and Hong Kong, receiving the "Golden Bauhinia Awards" will serve as a driver for the Company's high-quality development. Going forward, China Unicom will adhere to the main keynote of "upholding integrity and fostering innovation, and advancing steadily for long-term growth", focus on the core arenas of "connectivity", "computing", "service" and "security", continuously improve the long-term mechanism for market value management, deepen its classified and differentiated investor relations management, steadily enhance the standard of compliant information disclosure, and create greater value for shareholders, customers, employees and society. - End - For media enquiries, please contact: China Unicom (Hong Kong) Limited Corporate Affairs Department Mr. Chris Chen Tel: (852) 2121 3212 Email: chris@chinaunicom.com.hk 30/01/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
More

Huitongda Network (9878.HK) Received Listing Approval for H Share Full Circulation, Unleashes Market Liquidity and Growth Potential

January 29, 2026
EQS via SeaPRwire.com / 30/01/2026 / 14:45 UTC+8 Huitongda Network (9878.HK) recently announced that it has received the filing notice by the CSRC and the listing approval by the Hong Kong Stock Exchange regarding its application for the full circulation of H shares. This marks a key step in the company’s efforts to optimize its capital structure and enhance market liquidity. Upon the completion of H share full circulation, Huitongda’s negotiable market capitalization is expected to significantly increase, which would in turn create strong market awareness and valuation recovery momentum. Increasing Circulating Shares to Boost Trading Activity According to the announcement, the number of H shares in circulation will increase by approximately twofold upon the completion of conversion and procedures, leading to a substantial increase in public float. Stock analysts generally believe that such an increase will optimize trading structure, encourage market participation, and attract more institutional investors and passive funds. In the Hong Kong stock market, liquidity has been one of the key factors influencing valuation. With a material increase in free float, it is expected that Huitongda will see an improved pricing efficiency in the secondary market, laying the foundation for a proper reflection of its intrinsic value. Based on its recent share price performance, the market has also responded favourably towards the expected improvement in fundamentals and its progress in H share full circulation, with the share price standing firm above the HK$10 mark. The company, especially its upcoming performance, is expected to be increasingly under investors’ radar. Earnings Growth, Share Repurchase, and Dividend Distribution to Progressively Realize Its Capital Market Strategy While optimizing its capital structure, Huitongda has been steadily implementing its plans for business growth and improving shareholders’ return. The expectation of “earnings growth + share repurchase plan + dividend distribution” has essentially formed a positive feedback loop, garnering investors’ attention. On operations, Huitongda remains committed to pursuing high-quality growth, seeking strategic transformation by focusing on supply chain upgrades, self-owned brands development, and AI empowerment. The market remains optimistic over its prospects of achieving a double-digit earnings growth in the future. Supported by the substantial improvement in profitability, Huitongda may also enter a window of valuation recovery. In terms of shareholders’ return, Huitongda has used its capital reserves to offset accumulated losses, reducing its accumulated losses to RMB0. This has essentially removed the key potential obstacle in dividend distribution, laying the foundation for a stable dividend policy in the future. Considering its strong cash position and stable cash flow performance, the possibility of a dividend return should further boost its market performance. In addition, Huitongda previously announced a share repurchase plan of up to RMB500 million, and has backed up its confidence with a series of repurchase activities. According to public disclosure, since 25 November 2025, Huitongda has repurchased its shares for 20 trading days, buying a total of 1,395,700 shares over the past two months. The sustained buyback activities have provided solid support to its share price, while also highlighting management’s confidence and recognition of its long-term value. Liquidity Enhancement and Fundamental Improvement to Drive Re-rating From a medium-to-long-term perspective, H share full circulation is not merely a one-off capital structure movement, but an important milestone in Huitongda’s strategic transition. On the one hand, the expansion of free float is expected to enhance market liquidity and facilitate broader investor participation; on the other hand, with a clear path to earnings growth, the improvement in underlying fundamentals is also providing a strong support for valuation recovery. On the combination of “full share circulation + share repurchase + dividend distribution”, Huitongda’s capital market narrative is becoming increasingly clear, forming a positive loop with improved liquidity to boost market attention; earnings recovery to strengthen underlying fundamentals, and enhanced shareholders’ return to induce investment appetite. To Huitongda, the market believes that the implementation of H share full circulation will open new and broader capital market channels for the company. As Huitongda continues to deliver on its business and capital market initiatives, it may be at the inflection point of revaluation, entering a new phase of strong share price performance. 30/01/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
More